Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases.

Source:http://linkedlifedata.com/resource/pubmed/id/18425387

Download in:

View as

General Info

PMID
18425387